← 返回產品資料庫

⚠️ 此醫材許可證已註銷

狀態:已註銷 日期:2012/11/27

原因:許可證已逾有效期

"亞特斯" 類胰島素生長因子第一型(不萃取)放射免疫分析試劑

🩺 醫材

"Adaltis" Non-Extraction IGF-1 Bridge

衛署醫器輸字第015166號

GDP 認證供應商

醫材分類

  • A.1370人體生長激素試驗系統

醫器規格

#142800 100 tests

限制項目

輸 入

適應症

用來定量檢測人體血清或EDTA血漿中類胰島素生長因子第一型(IGF-1)的含量。

醫材資訊

主成分
1. IGF-1 Standards (lyophilized): 6 vials, labeled A-F, containing concentrations of approximately 0-8-30-100-300-1000 ng/mL (1.1-130 nmol/L) of IGF I in a protein-based (BSA) buffer.\n2. Anti-IGF-1 [I-125] Reagent (red): 1 bottle, 22 mL, containing <370 kBq of I-125-labeled anti-IGF-1 in a protein-based (BSA) buffer.\n3. Anti-IGF-1 Coated Tubes (metallic light green rim): 100 tubes with Anti-IGF-1 immunoglobulin immobilized to the inside walf for each tube.\n4. Sample Diluent: 1 bottle, 105 mL, containing sample buffer.\n5. Wash Concentrate B 25X: 1 bottle, 60 mL, containing buffer with a non-ionic detergent.\n6. IGF-1 Controls (Lyophilized): 2 vials, Level I and Level II, containing low and high concentrations of IGF-1 in a protein-based (BSA) buffer.\n
製造商
ADALTIS ITALIA S.P.A.
製造國
IT
申請商
泰歷藥品儀器股份有限公司
有效日期
2010/12/01
發證日期
2005/12/01

供應藥局

目前尚無登錄供應此品項的藥局資料。